252 related articles for article (PubMed ID: 31243081)
21. Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems.
Filippova J; Matveeva A; Zhuravlev E; Stepanov G
Biochimie; 2019 Dec; 167():49-60. PubMed ID: 31493470
[TBL] [Abstract][Full Text] [Related]
22. Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum.
Arranz-Solís D; Regidor-Cerrillo J; Lourido S; Ortega-Mora LM; Saeij JPJ
Int J Parasitol; 2018 Jul; 48(8):597-600. PubMed ID: 29625127
[TBL] [Abstract][Full Text] [Related]
23. Genome Editing Using CRISPR/Cas9 System in the Rice Blast Fungus.
Arazoe T
Methods Mol Biol; 2021; 2356():149-160. PubMed ID: 34236684
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9 and glycomics tools for
Gas-Pascual E; Ichikawa HT; Sheikh MO; Serji MI; Deng B; Mandalasi M; Bandini G; Samuelson J; Wells L; West CM
J Biol Chem; 2019 Jan; 294(4):1104-1125. PubMed ID: 30463938
[TBL] [Abstract][Full Text] [Related]
25. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
26. Use of CRISPR-Cas9 To Target Homologous Recombination Limits Transformation-Induced Genomic Changes in Candida albicans.
Marton T; Maufrais C; d'Enfert C; Legrand M
mSphere; 2020 Sep; 5(5):. PubMed ID: 32878930
[TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
Hiranniramol K; Chen Y; Wang X
Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
[TBL] [Abstract][Full Text] [Related]
28. A Universal, Genomewide GuideFinder for CRISPR/Cas9 Targeting in Microbial Genomes.
Spoto M; Guan C; Fleming E; Oh J
mSphere; 2020 Feb; 5(1):. PubMed ID: 32051236
[TBL] [Abstract][Full Text] [Related]
29. Conditional editing of the
Wang BZ; Zhang C; Zhang JL; Sun J
Yi Chuan; 2023 Jul; 45(7):593-601. PubMed ID: 37503583
[TBL] [Abstract][Full Text] [Related]
30. Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.
Kundert K; Lucas JE; Watters KE; Fellmann C; Ng AH; Heineike BM; Fitzsimmons CM; Oakes BL; Qu J; Prasad N; Rosenberg OS; Savage DF; El-Samad H; Doudna JA; Kortemme T
Nat Commun; 2019 May; 10(1):2127. PubMed ID: 31073154
[TBL] [Abstract][Full Text] [Related]
31. "Split-and-Click" sgRNA.
Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9 Based Genome Editing of Penicillium chrysogenum.
Pohl C; Kiel JA; Driessen AJ; Bovenberg RA; Nygård Y
ACS Synth Biol; 2016 Jul; 5(7):754-64. PubMed ID: 27072635
[TBL] [Abstract][Full Text] [Related]
33. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
[TBL] [Abstract][Full Text] [Related]
34. Unpredicted central inversion in a sgRNA flanked by inverted repeats.
Wang G; Sukumar S
Mol Biol Rep; 2020 Aug; 47(8):6375-6378. PubMed ID: 32424520
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
36. Genome Editing: CRISPR-Cas9.
Hoof JB; Nødvig CS; Mortensen UH
Methods Mol Biol; 2018; 1775():119-132. PubMed ID: 29876814
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 with single guide RNA expression driven by small tRNA promoters showed reduced editing efficiency compared to a U6 promoter.
Wei Y; Qiu Y; Chen Y; Liu G; Zhang Y; Xu L; Ding Q
RNA; 2017 Jan; 23(1):1-5. PubMed ID: 27742910
[TBL] [Abstract][Full Text] [Related]
38. Simplification of nutritional conditions in transformation procedures for genome editing with the CRISPR/Cas9 system for fission yeast.
Li S; Toya M; Sato M
Gene; 2021 Jun; 784():145595. PubMed ID: 33775846
[TBL] [Abstract][Full Text] [Related]
39. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
Najah S; Saulnier C; Pernodet JL; Bury-Moné S
BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
[TBL] [Abstract][Full Text] [Related]
40. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
